The optimal occasions for CsA withdrawal after kidney transplantation
10.3760/cma.j.issn.0254-1785.2010.05.008
- VernacularTitle:肾移植受者停用环孢素A时机的探讨
- Author:
Yuehui ZHANG
;
Jianyu LING
- Publication Type:Journal Article
- Keywords:
Kidney transplantation;
Cyclosporine;
Drug withdrawal;
Risk assessment;
Treatment outcome
- From:
Chinese Journal of Organ Transplantation
2010;31(5):284-286
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss the optimal occasions for CsA withdrawal after kidney transplantation. Methods Thirty-eight cases of kidney transplantations in out-clinic were included in this study. CsA was withdrawn in their immunosuppressive regimen owing to different reasons after operation.All patients were followed up at least 2 years after operation, and followed up more than 12 months after CsA withdrawal. All patients were divided to two groups: Group A (18 cases), control group; group B (20cases), the CsA withdrawal owing its side effects. Acute rejection rate, SCr, uromicroprotein and side effects were analyzed in order to find the optimal occasions for CsA withdrawal Results CsA was re-administered in 9 cases (50 0/4) owing to different reasons in Group A. In group B, CsA was withdrawn due to gradually increased Scr and proteinuria in 12 cases, CsA related acute toxidty in 2 cases, hepatic injury in 8 cases and other reasons in 2 cases, After withdrawal of CsA, renal function was improved and hepatic injuries were recovered. Conclusion The suitable opportunity for CsA withdrawal for long-term survival patients should be at the beginning of gradually increased Scr and/or proteinuria. For the patients with normal and stable renal function and having no CsA related side effects, small dosage (1.5-2. 0 mg/kg)of CsA was the choice for the maintenance therapy.
